MRNA

Moderna

$27.54

-0.95 (-3.33%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 07.10.2025
$44.25
(+60.68%)
Strong Buy: 1
Buy: 4
Hold: 15
Sell: 1
Strong Sell: 3
Description:
Moderna, Inc. is a leading biotechnology company headquartered in Cambridge, Massachusetts, specializing in the development of messenger RNA (mRNA) technology for vaccine and therapeutic applications. Renowned for its pivotal role in combating infectious diseases, notably its COVID-19 vaccine, Moderna is expanding its portfolio to address a diverse range of health conditions, including immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune disorders. With a strong focus on innovation and a robust pipeline, Moderna aims to transform the landscape of medicine through its groundbreaking mRNA platform.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
325 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142
Fiscal year end:
December
Market capitalization:
$11.1 Billion
EBITDA:
-$3.06 Billion
PERatio:
0.0
EPS:
-7.51
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
2.007

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 7 years:
+39%
How much will you get:
$1,389
Prices dates:
07-12-2018: $18.60 and 30-09-2025: $25.83